CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 976930-977016 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Anti-ergotypic T cell responses in healthy controls and multiple sclerosis patients N.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T37252","span":{"begin":0,"end":86},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T37252","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T184","span":{"begin":0,"end":86},"obj":"Sentence"}],"attributes":[{"subj":"T184","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6065","span":{"begin":56,"end":74},"obj":"Disease"},{"id":"T69743","span":{"begin":56,"end":74},"obj":"Disease"}],"attributes":[{"id":"A6065","pred":"mondo_id","subj":"T6065","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A35045","pred":"mondo_id","subj":"T69743","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"subj":"T6065","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T69743","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#eca793","default":true},{"id":"CORD-19_Custom_license_subset","color":"#9398ec"},{"id":"CORD-19-PD-MONDO","color":"#b2ec93"}]}]}}